[Phenylhydrargyrum boricum in glycerin (Glycero-Merfen) in young children: undesirable mercury resorption in mouth mucosa even when free of lesions].
The formulation of phenylhydrargyrum boricum in glycerine (Glycero-Merfen) being frequently used in infants and young children, attention is drawn to the potentially symptomatic mercury absorption associated with its topical administration in that age group. This finding applies to both inflamed and normal oral mucosa. The use of this drug formulation in pediatric patients should be avoided.
D000042:Absorption; D000287:Administration, Topical; D002675:Child, Preschool; D006801:Humans; D006993:Hypnotics and Sedatives / Q000008:administration & dosage / Q000009:adverse effects*; D007223:Infant; D008628:Mercury / Q000378:metabolism*; D009061:Mouth Mucosa / Q000378:metabolism*; D010663:Phenylmercury Compounds / Q000008:administration & dosage / Q000009:adverse effects*
D006993:Hypnotics and Sedatives; D010663:Phenylmercury Compounds; D008628:Mercury; C008371:phenylmercury borate
Phenylmercuriborat in Glycerin (Glycero-Merfen) im Kleinkindesalter: unerwünschte Quecksilberresorption auch bei intakter Mundschleimhaut.